Skip to main content

Advertisement

SpringerLink
Log in

CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy

  • Original Article
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

We herein report on a nationwide survey conducted in Italy to investigate the use of parathyroidectomy (PTX). In spite of the availability of newer and more effective drugs to control chronic kidney disease mineral bone disorder (CKD-MBD) biochemical abnormalities, PTX still remains a resource for nephrologists to use. However, observational analyses suggest that in recent years there has been a constant decline in the number of patients undergoing PTX. The reasons are not clear, though the increasing age and number of comorbidities of dialysis patients may partly explain this trend. Poor adherence to guidelines and/or geographical as well as logistic factors may also contribute to the lower use of PTX. The working group on CKD-MBD of the Italian Society of Nephrology launched a nationwide survey to investigate clinical practice patterns for PTX in Italy and identify modifiable factors that may limit accessibility to surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Moe S, Drueke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945–1953

    Article  PubMed  CAS  Google Scholar 

  2. Yamamoto S, Fukagawa M (2017) Uremic Toxicity and Bone in CKD. J Nephrol 30:623–627

    Article  PubMed  Google Scholar 

  3. Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218

    Article  PubMed  CAS  Google Scholar 

  4. Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913–921

    Article  PubMed  CAS  Google Scholar 

  5. Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int 92:26–36

    Article  PubMed  Google Scholar 

  6. Kidney Disease: Improving Global Outcomes CKDMBDWG (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl S1–130

  7. Cozzolino M, Tomlinson J, Walsh L et al (2015) Emerging drugs for secondary hyperparathyroidism. Expert Opin Emerg Drugs 20:197–208

    Article  PubMed  CAS  Google Scholar 

  8. Tartaglione L, Pasquali M, Rotondi S et al (2017) Positioning novel biologicals in CKD-mineral and bone disorders. J Nephrol 30:689–699

    Article  PubMed  CAS  Google Scholar 

  9. Apetrii M, Goldsmith D, Nistor I et al (2017) Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) - A systematic review and meta-analysis. PLoS One 12:e0187025

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mazzaferro S, Brancaccio D, Messa P et al (2011) Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey. J Nephrol 24:225–235

    Article  PubMed  Google Scholar 

  11. Li S, Chen YW, Peng Y et al (2011) Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007. Am J Kidney Dis 57:602–611

    Article  PubMed  Google Scholar 

  12. Messa P (2015) Parathyroidectomy and patient survival in CKD patients. Nephrol Dial Transplant 30:1944–1946

    Article  PubMed  PubMed Central  Google Scholar 

  13. Tentori F, Zepel L, Fuller DS et al (2015) The DOPPS practice monitor for US dialysis care: PTH levels and management of mineral and bone disorder in US hemodialysis patients. Am J Kidney Dis 66:536–539

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tentori F, Wang M, Bieber BA et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10:98–109

    Article  PubMed  CAS  Google Scholar 

  15. Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482–2494

    Article  PubMed  CAS  Google Scholar 

  16. Parfrey PS, Chertow GM, Block GA et al (2013) The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab 98:4834–4844

    Article  PubMed  CAS  Google Scholar 

  17. van der Plas WY, Dulfer RR, Engelsman AF et al (2017) Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review. Nephrol Dial Transplant 32:1902–1908

    Article  PubMed  Google Scholar 

  18. Chen L, Wang K, Yu S et al (2016) Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis. Ren Fail 38:1050–1058

    Article  PubMed  CAS  Google Scholar 

  19. Ishani A, Liu J, Wetmore JB et al (2015) Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol 10:90–97

    Article  PubMed  CAS  Google Scholar 

  20. Locatelli F, Messa P, Bellasi A et al (2013) What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results. G Ital Nefrol 30

  21. Belozeroff V, Chertow GM, Graham CN et al (2015) Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial. Value Health 18:1079–1087

    Article  PubMed  Google Scholar 

  22. Gallieni M, De Luca N, Santoro D et al (2016) Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study. J Nephrol 29:71–78

    Article  PubMed  CAS  Google Scholar 

  23. Li JG, Xiao ZS, Hu XJ et al (2017) Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients. Medicine (Baltimore) 96:e9050

    Article  Google Scholar 

  24. Minuto M, Vera L, Ansaldo GL et al (2014) Modern approach to parathyroidectomy. G Ital Nefrol 31

Download references

Acknowledgements

The working group on CKD-MBD of the Italian Society thanks all centers that responded to the survey. A complete list of the centers is available in Supplementary Table 1.

Author information

Authors and Affiliations

  1. Nephrology and Dialysis Unit, ASST-Lariana, Como, Italy

    Antonio Bellasi

  2. Struttura Complessa di Nefrologia e Dialisi, P.O.C. “S.S. Annunziata”, A.S.L. Taranto, Taranto, Italy

    Luigi Morrone

  3. Ospedale N.S. di Bonaria, San Gavino Mon.le, Cagliari, Italy

    Maria Cristina Mereu

  4. Centro di Riferimento di Nefrologia e Dialisi, Ospedale Belcolle, Viterbo, Italy

    Carlo Massimetti

  5. U.O.C. Nefrologia, Dialisi e Trapianto, Azienda Ospedaliera Universitaria Sant’Orsola-Malpighi, Bologna, Italy

    Elena Pelizzaro & Giuseppe Cianciolo

  6. UOC Nefrologia-Azienda Ospedaliero-Universitaria Policlinico Umberto I Roma, Rome, Italy

    Marzia Pasquali

  7. UOC di Nefrologia, Dialisi e Trapianto del GOM “BMM” di Reggio Calabria, Reggio Calabria, Italy

    Vincenzo Panuccio

Authors
  1. Antonio Bellasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luigi Morrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Cristina Mereu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlo Massimetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elena Pelizzaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giuseppe Cianciolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marzia Pasquali
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vincenzo Panuccio
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the working group on CKD-MBD of the Italian Society of Nephrology

Corresponding author

Correspondence to Antonio Bellasi.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to disclose.

Research involving human participants and/or animals and informed consent

For this type of study formal ethical approval and informed consent are not required.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 22 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellasi, A., Morrone, L., Mereu, M.C. et al. CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy. J Nephrol 31, 585–591 (2018). https://doi.org/10.1007/s40620-018-0481-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-018-0481-7

Keywords

Search

Navigation